230 related articles for article (PubMed ID: 22275114)
1. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.
Thompson VC; Day TK; Bianco-Miotto T; Selth LA; Han G; Thomas M; Buchanan G; Scher HI; Nelson CC; ; Greenberg NM; Butler LM; Tilley WD
Int J Cancer; 2012 Aug; 131(3):662-72. PubMed ID: 22275114
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Han G; Buchanan G; Ittmann M; Harris JM; Yu X; Demayo FJ; Tilley W; Greenberg NM
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1151-6. PubMed ID: 15657128
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic potential of a prostate cancer-derived androgen receptor mutant.
Shi XB; Xue L; Tepper CG; Gandour-Edwards R; Ghosh P; Kung HJ; DeVere White RW
Prostate; 2007 May; 67(6):591-602. PubMed ID: 17262801
[TBL] [Abstract][Full Text] [Related]
4. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
Marques RB; Erkens-Schulze S; de Ridder CM; Hermans KG; Waltering K; Visakorpi T; Trapman J; Romijn JC; van Weerden WM; Jenster G
Int J Cancer; 2005 Nov; 117(2):221-9. PubMed ID: 15900601
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.
Masiello D; Chen SY; Xu Y; Verhoeven MC; Choi E; Hollenberg AN; Balk SP
Mol Endocrinol; 2004 Oct; 18(10):2388-401. PubMed ID: 15256534
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
9. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
10. Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.
Han G; Foster BA; Mistry S; Buchanan G; Harris JM; Tilley WD; Greenberg NM
J Biol Chem; 2001 Apr; 276(14):11204-13. PubMed ID: 11063747
[TBL] [Abstract][Full Text] [Related]
11. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
14. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
[TBL] [Abstract][Full Text] [Related]
15. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O
Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
Bennett NC; Hooper JD; Johnson DW; Gobe GC
Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
[TBL] [Abstract][Full Text] [Related]
17. Role of androgen receptor in prostatic neoplasia versus hyperplasia.
Husain I; Shukla S; Soni P; Husain N
J Cancer Res Ther; 2016; 12(1):112-6. PubMed ID: 27072221
[TBL] [Abstract][Full Text] [Related]
18. Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Moehren U; Papaioannou M; Reeb CA; Grasselli A; Nanni S; Asim M; Roell D; Prade I; Farsetti A; Baniahmad A
FASEB J; 2008 Apr; 22(4):1258-67. PubMed ID: 17991730
[TBL] [Abstract][Full Text] [Related]
19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
Mashima T; Okabe S; Seimiya H
Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]